Innovent Biologics Stock Analysis

Innovent Pink Sheet Analysis Notes

About 44.0% of the company shares are owned by institutional investors. The book value of Innovent Biologics was currently reported as 6.54. The company recorded a loss per share of 0.32. Innovent Biologics had not issued any dividends in recent years. Innovent Biologics, Inc. operates as a biopharmaceutical company in China. Innovent Biologics, Inc. was incorporated in 2011 and is headquartered in Suzhou, the Peoples Republic of China. Innovent Biologics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5538 people.The quote for Innovent Biologics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Innovent Biologics call the company at 86 512 6956 6088 or check out https://www.innoventbio.com.

Innovent Biologics Investment Alerts

Innovent Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innovent Biologics's market, we take the total number of its shares issued and multiply it by Innovent Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Innovent Profitablity

The company has Profit Margin (PM) of (0.68) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.78.

Technical Drivers

As of the 3rd of December, Innovent Biologics retains the Risk Adjusted Performance of (0.02), market risk adjusted performance of 0.122, and Standard Deviation of 3.73. Innovent Biologics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Innovent Biologics variance and potential upside to decide if Innovent Biologics is priced fairly, providing market reflects its last-minute price of 4.85 per share. Given that Innovent Biologics has information ratio of (0.07), we strongly advise you to confirm Innovent Biologics's regular market performance to make sure the company can sustain itself at a future point.

Innovent Biologics Price Movement Analysis

Innovent Biologics Predictive Daily Indicators

Innovent Biologics Forecast Models

Innovent Biologics' time-series forecasting models are one of many Innovent Biologics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innovent Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Innovent Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Innovent shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Innovent Biologics. By using and applying Innovent Pink Sheet analysis, traders can create a robust methodology for identifying Innovent entry and exit points for their positions.

When running Innovent Biologics' price analysis, check to measure Innovent Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovent Biologics is operating at the current time. Most of Innovent Biologics' value examination focuses on studying past and present price action to predict the probability of Innovent Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovent Biologics' price. Additionally, you may evaluate how the addition of Innovent Biologics to your portfolios can decrease your overall portfolio volatility.